Form D · Biotechnology

BELLUS Health Inc.

Laval, A8 · CIK 0001259942

Offering snapshot reported Jan 29, 2019 · SEC filing

Reported sold
$24M
Offering amount: $24M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 18, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12M$24MJan 11, 2019: $1,291,591.00Jan 11, 2019Jan 29, 2019: $23,970,494.00Jan 29, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,291,591 → $23,970,494
  • Reported investors2 → 14

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 29, 2019Amendment$23,970,494$22,678,903vs Jan 11, 201914SEC filing
Jan 11, 2019Initial$1,291,591No comparison2SEC filing
Dec 21, 2017Initial$9,608,732No comparison8SEC filing
May 15, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.21M (estimated)
Finders' fees
$0
Form D file number
021-330261
CONVERTED FROM CANADIAN DOLLARS USING THE BANK OF CANADA EXCHANGE RATE ON DECEMBER 18, 2018.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANoneHAYWOOD SECURITIES (USA) INC. · CRD 42072

Source: Form D, filed Jan 29, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Francesco Bellini Director
Roberto Bellini Director, Executive
Youssef L. Bennani Director
Franklin Berger Director
Clarissa Desjardins Director
Francois Desjardins Executive
Denis Garceau Executive
Chau Quang Khuong Director
Pierre Larochelle Director
Tony Matzouranis Executive
Joseph Rus Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
275 Armand Frappier Blvd.
Laval, A8, H7V 4A7